Publication for SelectivitySelectR
HMS LINCS and Druggable Genome Centers, Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA, USA; Department of Systems Biology, Harvard Medical School, Boston, MA, USA; Division of Biostatistics and Bioinformatics, Department of Environmental Health, University of Cincinnati, Cincinnati, OH, USA; Novartis Institutes for BioMedical Research Inc., Cambridge, MA, USA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA
SelectivitySelectR funding source(s)
Supported by NIH grants U54-HL127365, U24-DK116204, U54-HL127624 and by the Novartis Institutes for BioMedical Research.
Be the first to review SelectivitySelectR